•
Nov 1, 2024
Oct 31, 2024
Nov 2, 2024
Oct 30, 2024
Oct 25, 2024
WASHINGTON (AP) — US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine.